Profile of Hemophagocytic Lymphohistiocytosis; Efficacy of Intravenous Immunoglobulin Therapy
|
|
- Marcia Walsh
- 5 years ago
- Views:
Transcription
1 Indian J Pediatr (December 2014) 81(12): DOI /s ORIGINAL ARTICLE Profile of Hemophagocytic Lymphohistiocytosis; Efficacy of Intravenous Immunoglobulin Therapy Sarala Rajajee & Indhumathi Ashok & Nitin Manwani & J. Rajkumar & Kalpana Gowrishankar & Ezhilarasi Subbiah Received: 29 August 2013 /Accepted: 10 April 2014 /Published online: 9 May 2014 # Dr. K C Chaudhuri Foundation 2014 Abstract Obective To study the profile of children with Hemophagocytic lymphohistiocytosis (HLH) and compare the outcome of treatment with intravenous immunoglobulin therapy and Dexamethasone vs. HLH-2004 protocol. Methods The present retrospective cohort study was conducted in a tertiary care pediatric hospital in Chennai. Children with a diagnosis of HLH admitted to the hospital from June 2008 through June 2011 were included. Medical records of the subjects were reviewed and their clinical and demographic profile studied. Difference in outcome between treatment modalities was analysed. Results Of the 40 children studied, all had fever of 38.5 C for more than 7 d. Splenomegaly was noted in 25 children at admission, but eventually occurred in all the patients. All children had bicytopenia. Mean laboratory values were as followsneutrophil count 3,400/cu.mm, hemoglobin 8.75 g/dl, platelet count 84,000/cu.mm, fasting triglycerides 358 mg/dl, ferritin 8,139 mg/dl and fibrinogen 137 mg/dl. All children had evidence of hemophagocytosis in bone marrow smear. Good outcome was seen in 19/22 children treated with IVIG therapy (Group 1) vs. 10/12 children treated with HLH-2004 protocol S. Rajajee: E. Subbiah Department of Pediatric Hematology, Kanchi Kamakoti Childs Trust Hospital, Chennai, India I. Ashok: N. Manwani : J. Rajkumar Department of Pediatrics, Kanchi Kamakoti Childs Trust Hospital, Chennai, India K. Gowrishankar Department of Pediatric Genetics, Kanchi Kamakoti Childs Trust Hospital, Chennai, India S. Rajajee (*) New #28, Old #19 Second Main Road, C.I.T Colony, Chennai , India saralarajajee@yahoo.com with etoposide, cyclosporine and Dexamethasone (Group 2), P=1.00. Good outcome was seen in 4/6 children treated with IVIG therapy followed by HLH-2004 protocol (Group 3). Serum ferritin levels of more than 3,000 mg/dl were present in 13 children. In this group, good outcome was seen in 7/8 patients treated with IVIG vs. 4/5 treated with the HLH-2004 protocol (P=1.00). Conclusions IVIG and HLH-2004 protocol may be equally effective in the management of HLH. IVIG may be a preferable initial regimen, to avoid the risk of secondary malignancy associated with etoposide. Keywords Hemophagocytic lymphohistiocytosis. Intravenous immunoglobulin Introduction Hemophagocytic lymphohistiocytosis (HLH) is a rare, fatal disorder of childhood, affecting predominantly the mononuclear phagocytic system. Majority of patients with hematologic disorders such as leukemia, lymphoma, and aplastic anemia are treated on well-controlled protocols that allow one to evaluate the effectiveness and adverse effects of different therapeutic regimens [1 5]. A conspicuous exception can be found in virus-associated hemophagocytic syndrome or hemophagocytic lymphohistiocytosis (HLH) [6 11], for which treatment tends to, vary from patient to patient and among small cohorts. Although etoposide-containing immunochemotherapy has become the recommended treatment for HLH, immunomodulatory therapy with corticosteroids, IVIG, or a combination of these agents continues to be widely used. To better assess the role of IVIG therapy and HLH 2004 protocol in the management of HLH, retrospective comparative analysis of the patients with this clinical diagnosis was conducted.
2 1338 Indian J Pediatr (December 2014) 81(12): The aim was to study the profile of children with HLH and to compare the outcome in children treated with immunomodulatory therapy (intravenous immunoglobulin and Dexamethasone) vs. those treated with HLH 2004 protocol (etoposide, cyclosporine, dexamethasone). Material and Methods This study was conducted at Kanchi Kamakoti Childs Trust hospital, a tertiary care hospital for children in Chennai, Tamil Nadu, India during the period June 2008 through June Case records of children who were admitted during the above period with the main diagnosis of HLH were reviewed and their clinical, demographic profile studied. Patients had to have at least one year of follow-up documented in medical records to be included in the study. For the purpose of present study, a case of HLH was defined as per the criteria of the Histiocyte society [12]. A diagnosis of HLH required the presence of fever >38.5 C persisting beyond seven days and splenomegaly with 1. Two of the following abnormalities: Anemia (<9 g/dl), Neutropenia (<1,000 cells/cu.mm), Thrombocytopenia (<100,000 cells/ cu.mm). 2. One of the following abnormalities: Hypertriglyceridemia (fasting TGL>265 mg/dl), hypofibrinogenemia (<150 mg/dl), hyperferritinemia (>500 mcg/l). 3. Hemophagocytosis in Bone marrow. Patients with suspected familial HLH were excluded. Familial HLH was identified using the following criteria- 1. Family history OR 2. Absence of history suggestive of preceding viral illness (such as Dengue or Epstein Barr virus) or febrile episode OR 3. Recurrence of HLH on follow-up examination Where, on the basis of the above mentioned criteria, there was suspicion for familial HLH, assessment of the Perforin gene was performed. Routine gene assessment could not be performed because of cost of the test. The variables like age, sex, symptoms, signs, laboratory findings were analyzed with group statistical and descriptive analysis along with independent sample test. Selection of IVIG vs. the HLH protocol for treatment was entirely at the discretion of the Consultant physician. Group 1 consisted of children treated with IVIG (Immunorel R ) of 1 gm/kg/d for 2 d, Group 2 consisted of children treated with the HLH-2004 protocol (etoposide, cyclosporine and Dexamethasone) and Group 3 consisted of patients treated with IVIG followed by the HLH-2004 protocol. IVIG was given at a dose of 1 g/kg/d for 2 d with Dexamethasone at 10 mg/m 2 /d for 7 d followed by 6 mg/m 2 /d till complete clinical and lab response. Supportive care was given in the form of packed red cells for severe anemia (less than 5 g/dl) and platelet concentrate if platelet counts was less than 20,000/cu.mm or in the presence of significant spontaneous bleeds. All patients were seen in follow-up visits at least once a month. Primary outcome assessment for purposes of this study was at the end of one year follow up. Good outcome was defined by the disappearance of fever, improvement in the clinical condition and a normalization of cell counts with Event Free Survival (EFS) of 12 mo (absence of disease activity measured by ferritin, TGL and LDH). Poor outcome was defined as worsening of clinical condition and occurrence of death. The outcomes of patients within the groups were analyzed with Pearson Chi square and Fisher Exact tests as appropriate. P value less than 0.05 was considered statistically significant. Results Forty children fulfilling the diagnostic criteria were studied. In three young infants where there was a suspicious family history; Perforin gene was assessed and was normal. The demographic profile of children in the study along with the duration of fever is shown in Table 1. Gastrointestinal symptoms in the form of abdominal pain, vomiting and abdominal distension were found to be more common and were present in 18 children associated with liver derangement and coagulation abnormalities. Neurological symptoms in the form of seizures, irritability were found in seven cases. Lymphadenopathy was present in 27 % of children and rash was seen in 25 % of children. Splenomegaly was noted in 25 children at admission, but gradually evolved over the period in the rest. Figure 1 depicts the distribution of symptoms and laboratory findings in all patients. Figure 2 depicts the distribution of gastrointestinal, neurological and respiratory symptoms in patients in the three treatment groups. Six children had parental consanguinity but none of the patients had a family history of HLH. Laboratory findings showed bicytopenia in all the children. The total neutrophil count ranged from 300 to 20,000 cells/cu.mm with a mean value of 3,400 cells/cu.mm. The hemoglobin levels ranged from 5.1 to 13.8 g/dl with mean of 8.75 g/dl. The platelet counts ranged from 10,000 to 95,000 cells/cu.mm with the mean being 84,000 cells/cu.mm. Fasting triglyceride levels ranged from 87 to 629 mg/dl with the mean of 358 mg/ dl. Serum ferritin levels ranged from 104 to 107,791 mcg/l with a mean value of 8,139 mg/dl. Out of 40 children with hyperferritinemia, 6 children had ferritin of more than 3,000 but less than 10,000 and 7 children had very
3 Indian J Pediatr (December 2014) 81(12): Table 1 Demographic profile and duration of fever of children included in the study Age Sex Fever duration Range y, Mean 4.3 y 22 Males, 18 Females Range 7 90 y, Mean 18 y high levels of ferritin of more than 10,000. Serum fibrinogen levels were between 30 to 173 mg/dl with mean of 137 mg/dl. Bone marrow showed evidence of hemophagocytosis in all the children. Serological tests in search of diagnosis showed positive Dengue IgM ELISA in seven children, EBV VCA IgM ELISA in eight children and HSV 2 IgM in two children. Then the baseline laboratory parameters prior to onset of treatment were compared between the three treatment groups. The findings are shown in Tables 2 and 3. Subsequently, response to treatment and outcome was assessed in the three groups. An initial clinical response to treatment was defined as the disappearance of all the clinical signs and symptoms of the disease with normalization of laboratory findings. Worsening of previous clinical manifestations or laboratory profile was considered evidence of disease progression for which switching of therapy was considered. Special reasons for therapy switch were persisting fever and reemergence of high fever after transient response. The group statistical analysis was done for the individual variables. The analysis showed that, all the clinical features and laboratory findings were distributed similarly across all the three groups. Of the total 22 cases treated with immunomodulation therapy (IVIG and Dexamethasone) 19 had a good outcome while ten of 12 children treated with HLH 2004 protocol (etoposide, cyclosporine and Dexamethasone) had a good outcome (P=1.00). In six children, where immunomodulation 100% 80% 60% 40% 20% 0% therapy was followed by initiation of HLH 2004 protocol, the outcome was good thereafter in four children and poor in two children. Serum ferritin levels of more than 3,000 mg/dl were present in 13 children. In this group, good outcome was seen in 7/8 patients treated with IVIG vs. 4/5 treated with the HLH-2004 protocol (P=1.00). There were no relapses seen in any of the groups- all patients either had a good outcome or died. Discussion 39% 11% 50% 46% IVIG (9, 2, 7) 23% 17% 31% HLH Protocol (6, 4, 3) 17% 66% BOTH (3, 1, 1) Gastrointestinal Neurological Respiratory Fig. 2 Distribution of symptoms in the three treatment groups Hemophagocytic lymphohistiocytosis is a disorder of the mononuclear phagocytic system where infiltrating lymphocytes and histiocytes destroy the CNS, bone marrow and other organs [1]. It is characterized by cytotoxic deficiency which leads to abnormal T-cell activation and inflammatory cytokine production, which drive disease development [2]. It is an Fig. 1 Distribution of symptoms and laboratory findings in all patients with HLH Hemophaocytosis 40 Hypofibrinogenemia 29 Hyperferritinemia 36 Hypertriglyceridemia 18 Thrombocytopenia 40 Neutropenia 22 Anemia 37 GI symptoms 18 CNS symptoms 7 Rash Lymphadenopathy
4 1340 Indian J Pediatr (December 2014) 81(12): Table 2 Hematological profile (neutrophil count, hemoglobin and platelet count) of the three treatment groups Variables Immunomodulatory group (IVIG + Steroid) HLH protocol group Those who received both Range Mean Range Mean Range Mean Neutrophils ,100 8, ,500 5,883 1,200 13,700 6,983 Hemoglobin Platelets 15,000 95,000 67,000 15,000 90,000 58,000 10,000 90,000 85,000 important clinical diagnosis in infants and children who present with prolonged fever, pancytopenia, splenomegaly, without evidence of aplastic anemia or malignancy. It occurs both as primary (familial) and secondary (infection associated) forms [1 5]. HLH being a disease of excessive immune activation, various forms of immunomodulatory therapy have been tried [13]. The treatment of HLH with intravenous immunoglobulin was once thought to be beneficial [14]. Yet definite evaluation of either IVIG or an IVIG plus corticosteroid combination in this disease is lacking. The exact mechanism by which IVIG exerts its immunomodulatory effects is uncertain [15] but may include alteration of the T cell activation and cytokine production [16]. The HLH study group began its first intervention treatment strategy using HLH-94 protocol. The present treatment protocol HLH 2004 has been designed for the primary, inherited disease FHL, as well as any severe form of HLH, in patients aged <18 y [18]. Steroids, cyclosporin and etoposide are the treatment agents used in the induction phase and the continuation phase for patients in this regimen [16]. Early introduction of etoposide based regimen is purported to be a critical factor in securing long-term survival in patients with HLH. However, there is increased risk of acute myeloid leukemia and myelodysplastic syndrome following the use of etoposide [18, 19]. Also the potential for neutropenia associated opportunistic infections [16] in patients treated with etoposide raises serious questions about intensive use of this agent. The overriding question which led to this study was, whether or not etoposide is essential for successful management of hemophagocytic disease. The clinical characteristics, laboratory data and treatment variables for both the groups are reported in the Tables 2 and 3. Patients in the present study met most of the HLH diagnostic criteria proposed by Henter et al. [20] and lacked a family history of HLH. The present study also revealed that all the features were equally distributed across the three groups. It also reveals that the use of treatment regimens with immunoglobulin and etoposide have been equally effective and have a similar outcome. Though this result is in contrast to the previous studies, considering the benefits of IVIG therapy in the form of short treatment, less adverse effects and less chance of opportunistic infections [21, 22] along with response that is equal to etoposide containing regimens, intravenous immunoglobulin may be tried as the first line of management in all cases of HLH. It may be possible to begin treatment with IVIG, switching to an HLH like protocol at the first sign of failure. Support for this strategy comes again from the observation that overall survival rates in the groups were not significantly different. Although this therapy with intravenous immunoglobulin may produce positive effects against HLH, its role in first line regimen is unclear and will likely require additional data on the efficacy of IVIG with careful evaluation in future prospective trials for any firm conclusions. Serum ferritin levels of more than 3,000 mg/dl were present in 13 children of whom 8 were treated with IVIG and 5 with HLH 2004 protocol. The outcome was good in 7 and bad in 1 in IVIG group. Likewise, good outcome was seen in 4 and bad outcome in 1 in the HLH 2004 protocol group. There was no statistical difference. Drawbacks in the index study are, it was a retrospective study; genetic analysis was not done in all cases (though done in three cases, for which the results came as negative); NK cell activity and soluble CD25 receptor assay could not be done in any child. Table 3 Laboratory profile (triglycerides, ferritin and fibrinogen levels) of the three treatment groups Variables Immunomodulatory group (IVIG + Steroid) HLH protocol group Those who received both Range Mean Range Mean Range Mean Triglycerides Ferritin ,744 6, ,791 5, ,085 1,117 Fibrinogen
5 Indian J Pediatr (December 2014) 81(12): Conclusions Thus, both IVIG therapy and HLH protocol 2004 were found to be equally efficient in the management of hemophagocytic lymphohistocytosis. The use of IVIG therapy may be considered in all patients as the initial regimen as the outcome is equally good compared to HLH 2004 protocol. HLH 2004 protocol may be considered in cases with poor clinical response or when there is evidence of disease progression. This may avoid etoposide induced toxicity. Contributions SR: Conceived the study, study design, data collection and analysis, helped writing, editing the manuscript and will act as guarantor for this paper; IA: Assisted with data collection, analysis and editing the manuscript; NM and RJ: Assisted with data collection and editing the manuscript; KG and ES: Helped conceive of the study, data collection, analysis and editing the manuscript. Conflict of Interest Source of Funding References None. None. 1. Imashuku S, Hibi S, Ohara T, Iwai A, Sako M, Kato M, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immunochemotherapy. Blood. 1999;93: Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+T cells and interferon gamma are essential for the disorder. Blood. 2004;104: Henter JI, Samuelsson-Horne A, Aricò M, Egeler RM, Elinder G, Filipovich AH, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100: Henter JI, Aricò M, Egeler RM, Elinder G, Favara BE, Filipovich AH, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study group of the Histiocyte Society. Med Pediatr Oncol. 1997;28: Henter JI, Elinder G, Öst Å. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol. 1991;18: Ramachandran B, Balasubramanian S, Abhishek N, Ravikumar KG, Ramanan AV. Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India. Indian Pediatr. 2011;48: Blanche S, Caniglia M, Fischer A, Griscelli C. Epstein-Barr virusassociated hemophagocytic syndrome: clinical presentation and treatment. Pediatr Hematol Oncol. 1989;6: Okuda T, Yumoto Y. Reactive hemophagocytic syndrome responded to combination chemotherapy with steroid pulse therapy. Rinsho Ketsueki. 1995;36: Tsuda H. The use of cyclosporin-a in the treatment of virusassociated hemophagocytic syndrome in adults. Leuk Lymphoma. 1997;28: Chen RL, Lin KH, Lin DT, Su IJ, Huang LM, Lee PI, et al. Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol. 1995;89: Chen JS, Lin KH, Lin DT, Chen RL, Jou ST, Su IJ. Longitudinal observation and outcome of non-familial childhood haemophagocytic syndrome receiving etoposide-containing regimens. Br J Haematol. 1998;103: Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet. 1987;1: Mahlaoui N, Ouachee-Chardin M, de Saint BG, Neven B, Picard C, Blanche S, et al. Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-centre retrospective report of 38 patients. Pediatrics. 2007;120:e Freeman B, Rathore MH, Salman E, Joyce MJ, Pitel P. Intravenously administered immune globulin for the treatment of infectionassociated haemophagocytic syndrome. J Pediatr. 1993;123: Mouthon L, Lacroix-Desmazes S, Pashov A, Kaveri SV, Kazatchkine MD. Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases. Rev Med Interne. 1999;20:423s 30s. 16. Campbell DE, Georgiou GM, Kemp AS. Pooled human immunoglobulin inhibits IL-4 but not IFN-gamma or TNF-alpha secretion following in vitro stimulation of mononuclear cells with staphylococcal superantigen. Cytokine. 1999;11: Henter JI1, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer Feb;48(2): Joel SP, Shah R, Clark PI, Slevin ML. Predicting etoposide toxicity: relationship to organ function and protein binding. J Clin Oncol. 1996;14: Gupta A, Tyrrell P, Valani R, Benseler S, Weitzman S, Abdelhaleem M. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;51: Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for HLH. Pediatr Blood Cancer. 2007;48: Larroche C, Bruneel F, André MH, Bader-Meunier B, Baruchel A, Tribout B, et al. Intravenously administered gamma-globulins in reactive hemophagocytic syndrome. Multicenter study to assess their importance, by the immunoglobulins group of experts of CEDIT of the AP-HP. Ann. Med Interne (Paris). 2000;151: Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytie lymphohistiocytosis. Blood. 2011;118:
Profile of Hemophagocytic Lymphohistiocytosis in Children in a Tertiary Care Hospital in India
R E S E A R C H P A P E R Profile of Hemophagocytic Lymphohistiocytosis in Children in a Tertiary Care Hospital in India B RAMACHANDRAN, S BALASUBRAMANIAN, N ABHISHEK, KG RAVIKUMAR AND AV RAMANAN* From
More informationCity Pediatric Meet-Dec 2011 SPECTRUM OF HLH. Spectrum of HLH. Dr.Revathi Raj s unit, Apollo Children s Hospital.
City Pediatric Meet-Dec 2011 SPECTRUM OF HLH Spectrum of HLH Dr.Revathi Raj s unit, Apollo Children s Hospital. Case 1 4 month male child /thriving well Fever - 5 days with cough O/E hepatospenomegaly
More informationHemophagocytic Lymphohistiocytosis Pre-HCT Data
Instructions for Hemophagocytic Lymphohistiocytosis Pre-HCT Data (Form 2039) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Hemophagocytic Lymphohistiocytosis
More informationHemophagocytic syndrome: a review of 18 pediatric cases
J Microbiol Immunol Infect 2004;37:157-163 Hemophagocytic syndrome: a review of 18 pediatric cases Chih-Jung Chen 1, Yhu-Chering Huang 1, Tang-Her Jaing 2, Iou-Jih Hung 2, Chao-Ping Yang 2, Luan-Yin Chang
More informationWarm Autoantibodies in a Patient with Hemophagocytic Lymphohistiocytosis: A Case Report
Warm Autoantibodies in a Patient with Hemophagocytic Lymphohistiocytosis: A Case Report Emily Coberly, MD Department of Pathology and Anatomical Sciences University of Missouri Columbia April 30, 2013
More informationHemophagocytosis on Bone Marrow Aspirate Cytology: Single Center Experience in North Himalayan Region of India
Original Article Hemophagocytosis on Bone Marrow Aspirate Cytology: Single Center Experience in North Himalayan Region of India Chandra H, Chandra S, Kaushik RM 1, Bhat NK 2, Shrivastava V Departments
More informationHaemophagocytic Lymphohistiocytosis Complicating Myelodysplasia
Haemophagocytic Lymphohistiocytosis Complicating Myelodysplasia Geraldine Quintero- Platt a, Carima Belleyo- Belkasem a, Taida Martín- Santos b, Onán Pérez- Hernández a, Emilio González- Reimers a a Internal
More informationHemophagocytic Lymphohistiocytosis Secondary to T cell/histiocyte-rich Large B-cell Lymphoma
Hemophagocytic Lymphohistiocytosis Secondary to T cell/histiocyte-rich Large B-cell Lymphoma Katherine Devitt, M.D., Benjamin Chen, M.D., Ph.D., Hongbo Yu, M.D., Ph.D., Bruce Woda, M.D. 1 1 Department
More informationHAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A GHANAIAN CHILD
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A GHANAIAN CHILD C. I. SEGBEFIA 1, 2, A. OSEI-WUSU 2, W. OBENG 2 and Y. DEI-ADOMAKOH 3 1 University of Ghana Medical School, Accra, Ghana, 2 Department of Child Health,
More informationHỘI CHỨNG THỰC BÀO MÁU. (HEMOPHAGOCYTIC LYMPHOHISTOCYTOSIS)
HỘI CHỨNG THỰC BÀO MÁU. (HEMOPHAGOCYTIC LYMPHOHISTOCYTOSIS) INTRODUTION. An aggressive and life-threatening syndrome of excessive immune activation. Was described in 1952. Most frequently affects infants
More informationHemophagocytosis on Bone Marrow Aspirate Cytology: Single Center Experience in North Himalayan Region of India
Original Article Hemophagocytosis on Bone Marrow Aspirate Cytology: Single Center Experience in North Himalayan Region of India Chandra H, Chandra S, Kaushik RM 1, Bhat NK 2, Shrivastava V Departments
More informationAdult hemophagocytic lymphohistiocytosis; the insidious assassin Steven Ruiz, DO; David Kaufman, MD; Yuebo Gan, MD; Omar Al Ustwani, MD*
Open Journal of Clinical & Medical Case Reports Volume 3 (2017) Issue 2 ISSN 2379-1039 Adult hemophagocytic lymphohistiocytosis; the insidious assassin Steven Ruiz, DO; David Kaufman, MD; Yuebo Gan, MD;
More informationDiffuse large B-cell lymphoma in an adolescent female presenting with Epstein-Barr virus-driven hemophagocytic lymphohistiocytosis: a case report
Altaf et al. Journal of Medical Case Reports 2012, 6:141 JOURNAL OF MEDICAL CASE REPORTS CASE REPORT Open Access Diffuse large B-cell lymphoma in an adolescent female presenting with Epstein-Barr virus-driven
More informationSPARN Guidelines for Initial Diagnosis of Macrophage Activation Syndrome
Background SPARN Guidelines for Initial Diagnosis of Macrophage Activation Syndrome MAS requires prompt recognition and aggressive treatment to prevent fatalities from this rare complication of rheumatological
More informationInternational Journal of Hematology Research
International Journal of Hematology Research Online Submissions: http://www.ghrnet.org/index./ijhr/ doi:10.6051/j.issn.2409-3548.2015.01.7 Int. J. Hematol Res 2015 April 1(1): 7-11 ISSN 2409-3548 (print)
More informationHAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH CHILDREN
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH CHILDREN Histiocytosis UK Introduction Despite the misery it causes, Histiocytosis is too rare a disease to have generated substantial research in medical circles.
More informationSevere Neutropenia in Dengue- look out for Hemophagocytic Lymphohistiocytosis
Open Journal of Clinical & Medical Case Reports Volume 2 (2016) Issue 9 Abstract ISSN 2379-1039 Severe Neutropenia in Dengue- look out for Hemophagocytic Lymphohistiocytosis Shamshersingh Gajendra Chauhan*;
More informationHaemophagocytic lymphohistiocytosis in Hong Kong children
M E D I C A L P R A C T I C E Haemophagocytic lymphohistiocytosis in Hong Kong children June SH Chan Matthew MK Shing Vincent Lee CK Li Patrick Yuen Haemophagocytic lymphohistiocytosis is a rare but potentially
More informationMorphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital
Morphology Case Study Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital 41 year old male presented to GP for routine check-up in May 2011. FBC Results:
More informationHuman herpesvirus-8 related hemophagocytic lymphohistiocytosis with Kaposi sarcoma in an immunocompetent HIV negative adult
www.edoriumjournals.com CASE REPORT PEER REVIEWED OPEN ACCESS Human herpesvirus-8 related hemophagocytic lymphohistiocytosis with Kaposi sarcoma in an immunocompetent HIV negative adult Talal Alnabelsi,
More informationChildhood macrophage activation syndrome differs from infection-associated hemophagocytosis syndrome in etiology and outcome in Taiwan
J Microbiol Immunol Infect. 2007;40:265-271 Chen et al Original Article Childhood macrophage activation syndrome differs from infection-associated hemophagocytosis syndrome in etiology and outcome in Taiwan
More informationDoes Morphology Matter in 2017
Does Morphology Matter in 2017 ISLH May 2017 Kathryn Foucar Distinguished Professor Emerita kfoucar@salud.unm.edu Objectives Recognize unique RBC and WBC abnormalities in non-neoplastic disorders Learn
More informationINFECTION-ASSOCIATED HEMOPHAGOCYTIC SYNDROME
INFECTION-ASSOCIATED HEMOPHAGOCYTIC SYNDROME Z.E. Currimbhoy ABSTRACT An epidemic of an infection associated with circulating hemophagocytes (HP) and activated monocytes (AM) was seen in Bombay. Although
More informationHAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH ADULTS & Young People
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS HLH ADULTS & Young People Histiocytosis UK Introduction Despite the misery it causes, Histiocytosis is too rare a disease to have generated substantial research in medical
More informationCME/SAM. Extreme Hyperferritinemia Causes and Impact on Diagnostic Reasoning
Extreme Hyperferritinemia Causes and Impact on Diagnostic Reasoning Katie Sackett, DO, MS, 1 Maros Cunderlik, 2 Nishant Sahni, MD, MS, 3 Anthony A. Killeen, MD, PhD, 1 and Andrew P. J. Olson, MD 4 From
More informationAcquired hemophagocytic lymphohistiocytosis associated with multiple myeloma
Med Oncol (2011) 28:539 543 DOI 10.1007/s12032-010-9484-5 ORIGINAL PAPER Acquired hemophagocytic lymphohistiocytosis associated with multiple myeloma Maciej Machaczka Johan Vaktnäs Monika Klimkowska Hareth
More informationFatal Haemophagocytic Syndrome
Fatal Haemophagocytic Syndrome SAW Fadl1ah, MMed', A A Raymond, MD", S K Cheong, FRCPA', MAL Amir, MD', 'Division ofclinical Haematology and Stem celltt'ansplantation, "Division ofneurology, Faculty of
More informationTreatment of haemophagocytic lymphohistiocytosis with cyclophosphamide, vincristine and prednisone
Published 3 February 2012, doi:10.4414/smw.2012.13512 Cite this as: Treatment of haemophagocytic lymphohistiocytosis with cyclophosphamide, vincristine and prednisone Yixin Hu*, Ji Xu*, Lingling Wang,
More informationScrub typhus associated with hemophagocytic lymphohistiocytosis: A report of six pediatric patients
EXPERIMENTAL AND THERAPEUTIC MEDICINE 12: 2729-2734, 2016 Scrub typhus associated with hemophagocytic lymphohistiocytosis: A report of six pediatric patients YINGKANG JIN 1, LI HUANG 2, HUIFENG FAN 1,
More informationHemophagocytic Lymphohistiocytosis CASE 07-5
CASE STUDIES IN CLINICAL LABORATORY SCIENCE Hemophagocytic Lymphohistiocytosis CASE 07-5 CLINICAL LABORATORY SCIENCE PROGRAM UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES GRAND FORKS,
More informationSalmonella Typhi Associated Hemophagocytic Lymphohistiocytosis in a Previously Healthy 23 Years Old Woman
Article ID: WMC001751 ISSN 2046-1690 Salmonella Typhi Associated Hemophagocytic Lymphohistiocytosis in a Previously Healthy 23 Years Old Woman Author(s):Dr. Dina Khalaf, Dr. Bassem Toema, Dr. Shaker Al-sadadi,
More informationPreface In recent years, the pathogenesis of hematological disorders in children has been clarified, which has led to remarkable progress in the treatment outcome for these disorders. In particular, molecular
More informationHEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SECONDARY TO RHEUMATOID ARTHRITIS L. Gautam Mukesh 1, K. Vengadakrishnan 2, A. K. Koushik 3
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS SECONDARY TO RHEUMATOID ARTHRITIS L. Gautam Mukesh 1, K. Vengadakrishnan 2, A. K. Koushik 3 HOW TO CITE THIS ARTICLE: L. Gautam Mukesh, K. Vengadakrishnan, A. K. Koushik.
More informationUNUSUAL PRESENTATION OF AN USUAL CAUSE OF THROMBOCYTOPENIA SOUTHERN RAILWAY HQ HOSPITAL, PERAMBUR DR. KUMARAN DNB PG
UNUSUAL PRESENTATION OF AN USUAL CAUSE OF THROMBOCYTOPENIA SOUTHERN RAILWAY HQ HOSPITAL, PERAMBUR DR. KUMARAN DNB PG 5 months old female infant hailing from Thoothukudi brought by her mother referred from
More informationDOI: /peds
Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis: A Single-Center Report of 48 Patients Marie Ouachée-Chardin, Caroline Elie, Geneviève de Saint Basile, Françoise Le Deist,
More informationSerum Neopterin Levels as a Diagnostic Marker of Hemophagocytic Lymphohistiocytosis Syndrome
CLINICAL AND VACCINE IMMUNOLOGY, Apr. 2011, p. 609 614 Vol. 18, No. 4 1556-6811/11/$12.00 doi:10.1128/cvi.00306-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Serum Neopterin
More informationEmapalumab for primary haemophagocytic lymphohistiocytosis
NIHR Innovation Observatory Evidence Briefing: February 2018 Emapalumab for primary haemophagocytic lymphohistiocytosis NIHRIO (HSRIC) ID: 8727 NICE ID: 8735 LAY SUMMARY Haemophagocytic lymphohistiocytosis
More informationNon-Familial Haemophagocytic Lymphohistiocytosis in Children
Non-Familial Haemophagocytic Lymphohistiocytosis in Children MC Hoh, MRCp, HP Lin, FRCp, Department of Paediatrics, University Hospital, 59100 Kuala Lumpur Introduction Haemophagocytic lymphohistiocytosis
More informationAutoimmune Lymphoproliferative Syndrome Misdiagnosed as Hemophagocytic Lymphohistiocytosis
CASE REPORT Autoimmune Lymphoproliferative Syndrome Misdiagnosed as Hemophagocytic Lymphohistiocytosis AUTHORS: Amanda Rudman Spergel, MD, a Kelly Walkovich, MD, b Susan Price, RN, a Julie E. Niemela,
More informationNeutropenia Following Intravenous Immunoglobulin Therapy in Pediatric Patients with Idiopathic Thrombocytopenic Purpura
ORIGINAL ARTICLE IJBC 2014;6(2): 81-85 Neutropenia Following Intravenous Immunoglobulin Therapy in Pediatric Patients with Idiopathic Thrombocytopenic Purpura Ansari S * 1, Shirali A 1, Khalili N 1, Daneshfar
More informationDefects of Innate Immunity
Defects of Innate Immunity TLR signalling IRAK4 and MyD88 AR Same clinical phenotype for both genes (Recurrent) invasive bacterial infections: Meningitis and septicemia >> skin Pneumococcus >> Staph aureus
More informationForm 2033 R3.0: Wiskott-Aldrich Syndrome Pre-HSCT Data
Key Fields Sequence Number: Date Received: - - CIBMTR Center Number: CIBMTR Recipient ID: Has this patient's data been previously reported to USIDNET? USIDNET ID: Today's Date: - - Date of HSCT for which
More informationHemophagocytic Syndrome in a Patient With Human Immunodeficiency Virus, Epstein-Barr Viremia, and Newly Diagnosed Hodgkin Lymphoma
H & 0 C l i n i c a l C a s e S t u d i e s Hemophagocytic Syndrome in a Patient With Human Immunodeficiency Virus, Epstein-Barr Viremia, and Newly Diagnosed Hodgkin Lymphoma Simon Khagi, MD 1 Olga Danilova,
More informationCircle Yes or No Y N. (Note: requests without this information will not be accepted.) [If no, then no further questions.]
04/25/2016 Prior Authorization AETA BETTER HEALTH OF LA MEDICAID Colony Stimulating Factors (LA88) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More informationHemophagocytic Syndrome Associated With Hematologic Malignancies
HOSPITAL CHRONICLES 2011, 6(3): 110 117 Review Hemophagocytic Syndrome Associated With Hematologic Malignancies Ifigenia Tzannou, MD, Artemisia-Magdalini Balta, MD, Maria Bakiri, MD Department of Hematology,
More informationDr.P.Subramani II year Postgraduate SRMC. Dr.Latha Ravichandran Professor Department of pediatrics
Dr.Latha Ravichandran Professor Department of pediatrics Dr.Julius Xavier Scott Professor Department of pediatric hematooncology Sri Ramachandra University, Porur. Dr.P.Subramani II year Postgraduate SRMC
More informationCircle Yes or Y N. [Note: requests without this information will not be accepted.] [If no, then no further questions.
10/01/2016 Prior Authorization Aetna Better Health of West Virginia COLO STIMULATIG FACTORS (WV88) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information,
More information2. Does the patient have a diagnosis of chronic idiopathic thrombocytopenic purpura (ITP)?
Pharmacy Prior Authorization MERC CARE (MEDICAID) Promacta (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax
More informationCauses, clinical symptoms, and outcomes of infectious diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults
Journal of Microbiology, Immunology and Infection (2011) 44, 191e197 available at www.sciencedirect.com journal homepage: www.e-jmii.com ORIGINAL ARTICLE Causes, clinical symptoms, and outcomes of infectious
More informationEpstein-Barr virus-associated infectious mononucleosis and risk factor analysis for complications in hospitalized children
J Microbiol Immunol Infect 2005;38:255-261 Tsai et al Epstein-Barr virus-associated infectious mononucleosis and risk factor analysis for complications in hospitalized children Ming-Han Tsai 1, Chih-Yi
More informationhemophagocytic lymphohistiocytosis; refractory celiac disease; ebstein barr virus; cutaneous leukocytoclastic vasculitis; immunocompromised patient
Open Journal of Clinical & Medical Case Reports Volume 3 (2017) Issue 23 ISSN 2379-1039 Hemophagocytic syndrome EBV-related associated with leukocytoclastic vasculitis in a type-2 refractory celiac patient
More informationJMSCR Vol 05 Issue 02 Pages February 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i2.56 Colonic Adenocarcinoma Presenting as Hemophagocytic
More informationPharmacy Prior Authorization
Pharmacy Prior Authorization MERC CARE (MEDICAID) Promacta (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign and date. Fax
More informationFei Li 1, Yijun Yang 2, Fengyan Jin 3, Casey Dehoedt 4, Jia Rao 1, Yulan Zhou 1,PuLi 1, Ganping Yang 1, Min Wang 5*, Rongyan Zhang 1* and Ye Yang 5*
Li et al. Orphanet Journal of Rare Diseases (2015) 10:20 DOI 10.1186/s13023-015-0224-y RESEARCH Open Access Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a
More informationHepatitis A Virus Infection Associated with Hemophagocytic Syndrome: Report of TwoCases
CASE REPORT Hepatitis A Virus Infection Associated with Hemophagocytic Syndrome: Report of TwoCases Masaaki Watanabe, Akitaka Shibuya, Junko Okuno, Tadanobu Maeda*, Shunpei Tamamaand Katsunori Saigenji
More informationAn Overview of Hemophagocytic Lymphohistiocytosis
An Overview of Hemophagocytic Lymphohistiocytosis Ysabella M. Esteban, MD; Jill L. O. de Jong, MD, PhD; and Melissa S. Tesher, MD ABSTRACT Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening
More informationFULMINANT HEPATIC FAILURE AS AN ONSET OF SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN CHILD - CASE REPORT
Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 7 (56) No. 2-2014 FULMINANT HEPATIC FAILURE AS AN ONSET OF SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN CHILD - CASE
More informationCase Report Epstein-Barr Virus-Related Hemophagocytic Lymphohistiocytosis: Hematologic Emergency in the Critical Care Setting
Case Reports in Hematology Volume 215, Article ID 491567, 6 pages http://dx.doi.org/1.1155/215/491567 Case Report Epstein-Barr Virus-Related Hemophagocytic Lymphohistiocytosis: Hematologic Emergency in
More informationPharmacy Prior Authorization
Pharmacy Prior Authorization AETA BETTER HEALTH PESLVAIA & AETA BETTER HEALTH KIDS Promacta (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
More information2. Is therapy prescribed by, or in consultation with, a hematologist and/or oncologist?
Pharmacy Prior Authorization AETA BETTER HEALTH EW JERSE (MEDICAID) Colony Stimulating Factors (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review
More informationeltrombopag (Promacta )
Applies to all products administered or underwritten by Blue Cross and Blue Shield of Louisiana and its subsidiary, HMO Louisiana, Inc.(collectively referred to as the Company ), unless otherwise provided
More informationExtreme hyperferritinemia in the setting of acute myeloid leukaemia: a case report of hemophagocytic lymphohistiocytosis
Case report Extreme hyperferritinemia in the setting of acute myeloid leukaemia: a case report of hemophagocytic lymphohistiocytosis Damien Denimal* 1, Louise Ménégaut 1, Cédric Rossi 2, Laurence Duvillard
More informationKikuchi-Fujimoto Disease Complicated with Reactive Hemophagocytic Lymphohistiocytosis
- Copyright 2016 by Okayama University Medical School. Case Report http ://escholarship.lib.okayama-u.ac.jp/amo/ Kikuchi-Fujimoto Disease Complicated with Reactive Hemophagocytic Lymphohistiocytosis a*
More informationAnesthesia recommendations for patients suffering from Macrophage activation syndrome
orphananesthesia Anesthesia recommendations for patients suffering from Macrophage activation syndrome Disease name: Macrophage activation syndrome ICD 10: D76.2 Synonyms: haemophagocytic lymphohistiocytosis,
More informationCase Report Hemophagocytic Syndrome Associated with Hodgkin s Lymphoma First Presenting as Fever and Pancytopenia
Case Reports in Medicine Volume 2010, Article ID 759651, 4 pages doi:10.1155/2010/759651 Case Report Hemophagocytic Syndrome Associated with Hodgkin s Lymphoma First Presenting as Fever and Pancytopenia
More informationFludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis
European Journal of Haematology ORIGINAL ARTICLE Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis Amir
More informationPlasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies
ORIGINAL ARTICLE Plasma Levels of Presepsin (Soluble CD14-subtype) as a Novel Prognostic Marker for Hemophagocytic Syndrome in Hematological Malignancies Satoru Nanno 1,HideoKoh 1, Takako Katayama 1, Masamichi
More informationClinical profile of ITP in Children: A single center study
Clinical profile of ITP in Children: A single center study Dr.Ramadan Allalous 1,Dr Fathia Alriani 1, Dr Amna Rayani 2. 1Tripoli ' s Medical center,medical Faculty, Tripoli University 2Tripoli Children
More informationHemophagocytic lymphohistiocytosis (HLH), also known
ORIGINAL ARTICLES 2 218 Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Analysis of 23 Patients in China Xiaoyan Shao MD 1 *, Ye Xu MD 2 *, Xihui Xu MD 1, Yong
More informationAutoimmune-Associated Hemophagocytic Syndrome/Macrophage Activation Syndrome
Autoimmune-Associated Hemophagocytic Syndrome/Macrophage Activation Syndrome Maciej Machaczka 1, Wojciech Sydor 2, Małgorzata Rucińska 3, Marta Szostek 3 and Jacek Musiał 2 1 Hematology Center, Karolinska
More informationThis was a multicenter study conducted at 11 sites in the United States and 11 sites in Europe.
Protocol CAM211: A Phase II Study of Campath-1H (CAMPATH ) in Patients with B- Cell Chronic Lymphocytic Leukemia who have Received an Alkylating Agent and Failed Fludarabine Therapy These results are supplied
More informationA rare thing may be just like any other but it is also paradoxically nothing like any of them.
A rare thing may be just like any other but it is also paradoxically nothing like any of them. A RARE ANEMIA WHERE THERE IS PAUCITY AMIDST PLENTY. Dr.Rena, DNB Pediatrics Resident, Dr.Mehta s Children
More informationHaematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis
research paper Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis AnnaCarin Horne, 1 Gritta Janka, 2 R. Maarten Egeler, 3 Helmut Gadner, 4 Shinsaku Imashuku, 5 Stephan Ladisch,
More informationCytopenias and clonal expansion of gamma/delta T-cells in a patient with anaplasmosis: a potential diagnostic pitfall.
J Clin Exp Hematop Vol. 56, No. 3, March 2017 Case Study Cytopenias and clonal expansion of gamma/delta T-cells in a patient with anaplasmosis: a potential diagnostic pitfall. Daniel Marko, 1) Anamarija
More informationResults. Clinical reports of transplant recipients
Cloning of EBV genes as fusion proteins with Renilla luciferase for Luciferase Immunoprecipitation System (LIPS) analysis A panel of 13 different EBV proteins was generated as Renilla luciferase (Ruc)
More information1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease
Hematology/Oncology Description: The pediatric hematology-oncology division sees a wide spectrum of pediatric disease including but not limited to leukemia, hemophilia, solid tumors, ITP, and other blood
More informationHemophagocytic lymphohistiocytosis complicating a T-cell rich B-cell lymphoma
Mahtat et al. BMC Hematology (2016) 16:28 DOI 10.1186/s12878-016-0065-5 CASE REPORT Hemophagocytic lymphohistiocytosis complicating a T-cell rich B-cell lymphoma Open Access El Mehdi Mahtat 1*, Maryem
More informationFamilial and Acquired Hemophagocytic Lymphohistiocytosis
Familial and Acquired Hemophagocytic Lymphohistiocytosis Gritta Janka and Udo zur Stadt Hemophagocytic lymphohistiocytosis (HLH) is a lifethreatening condition characterized by uncontrolled hyperinflammation
More informationHemophagocytic lymphohistiocytosis: pathogenesis and treatment
PEDIATRIC HEMATOLOGY:INSIGHTS APPLICABLE TO ALL! Hemophagocytic lymphohistiocytosis: pathogenesis and treatment Gritta E. Janka 1 and Kai Lehmberg 1 1 University Medical Center Eppendorf, Hamburg, Germany
More informationAdult cancer-related hemophagocytic lymphohistiocytosis a challenging diagnosis: a case report
Hust et al. Journal of Medical Case Reports (2017) 11:172 DOI 10.1186/s13256-017-1344-x CASE REPORT Open Access Adult cancer-related hemophagocytic lymphohistiocytosis a challenging diagnosis: a case report
More informationPharmacy Prior Authorization
Pharmacy Prior Authorization MERC CARE (MEDICAID) Colony Stimulating Factors (Medicaid) This fax machine is located in a secure location as required by HIPAA regulations. Complete/review information, sign
More informationAETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF)
AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) Colony Stimulating Factor (CSF) Neupogen (filgrastim; G-CSF), Neulasta (peg-filgrastim; G-CSF); Neulasa
More informationAn uncommon complication of a common disease
An uncommon complication of a common disease Inter-hospital Geriatric Meeting Speaker: Dr. Chan Fei Supervisor: Dr. James Luk 29 th Oct 2010 History F/78, Madam Ng Lives with son Non-smoker, non-drinker
More informationHemophagocytic Syndrome Associated with Herpes Virus 8 and Multicentric Castleman Diseases in a HIV-Negative Patient
JMID/ 2017; 7 (4):202-206 Journal of Microbiology and Infectious Diseases doi: 10.5799/jmid.369272 CASE REPORT Hemophagocytic Syndrome Associated with Herpes Virus 8 and Multicentric Castleman Diseases
More informationST. LUKE S MEDICAL CENTER INSTITUTE OF PATHOLOGY
ST. LUKE S MEDICAL CENTER INSTITUTE OF PATHOLOGY CASE REPORT Hemophagocytic lymphohistiocytosis with multifocal and multilevel involvement of the spinal cord: a case report Francisco Tria IV, MD., Marie
More informationEpstein Barr. hemophagocytic lymphohistiocytosis HLH FHL X EBV AHS EBV HLH NK HLH EBV HLH HLH FHL 2 HLH HLH EBV HLH
2010 Vol. 22No. 159 41 1 EpsteinBarr hemophagocytic lymphohistiocytosishlh EB HLH 3 1 HLHFHL HLH EBV 2 X XLPSAP 3 EBVHLH EB CAEBV 2 T NK EBV HLH 1 HLH HLHFHL 2 HLH EB EB HLH EBVHLH FHLX EBVAHS EBVHLHNK
More informationFever. National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital
Fever National Pediatric Nighttime Curriculum Written by Debbie Sakai, M.D. Institution: Lucile Packard Children s Hospital Case 1 4-month-old well-appearing girl admitted for croup and respiratory distress.
More informationMost Common Hemostasis Consults: Thrombocytopenia
Most Common Hemostasis Consults: Thrombocytopenia Cindy Neunert, MS MSCS Assistant Professor, Pediatrics CUMC Columbia University TSHNA Meeting, April 15, 2016 Financial Disclosures No relevant financial
More informationA Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014
A Practical Approach to Leukopenia/Neutropenia in Children Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014 Disclosures EPIC trial MAST Therapeutics SUSTAIN trial Selexys Pharmaceuticals
More informationOutline. What is aplastic anemia? 9/19/2012. Aplastic Anemia Current Thinking on the Disease, Diagnosis, and Non-Transplant Treatment Options
Aplastic Anemia Current Thinking on the Disease, Diagnosis, and Non-Transplant Treatment Options Carlos M. de Castro, MD Duke University Medical Center Outline What is Aplastic Anemia? What other diseases
More informationMacrophage activation syndrome as a complication of juvenile rheumatoid arthritis
European Review for Medical and Pharmacological Sciences 2017; 21: 4322-4326 Macrophage activation syndrome as a complication of juvenile rheumatoid arthritis Q. AN, M.-W. JIN, X.-J. AN, S.-M. XU, L. WANG
More information4100: Cellular Therapy Essential Data Follow-Up Form
4100: Cellular Therapy Essential Data Follow-Up Form Registry Use Only Sequence Number: Date Received: Key Fields CIBMTR Center Number: Event date: Visit: 100 day 6 months 1 year 2 years >2 years, Specify:
More informationStudy No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: TAG IDAG Objectives:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationJournal of Pediatric Critical Care P - ISSN: E - ISSN: Year: 2017 Volume: 4 Issue: 3 DOI /
Journal of Pediatric Critical Care P - ISSN: 2349-6592 E - ISSN: 2455-709 Year: 2017 Volume: 4 Issue: 3 DOI-10.21304/2017.0403.00202 Case Report Hemophagocytic lymphohistiocytosis presenting as septic
More informationAETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF)
AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Colony Stimulating Factor (CSF) Colony Stimulating Factor (CSF) Neupogen (filgrastim; G-CSF), Neulasta (peg-filgrastim; G-CSF); Neulasa
More informationDevelopment and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome
ARTHRITIS & RHEUMATOLOGY Vol. 66, No. 9, September 2014, pp 2613 2620 DOI 10.1002/art.38690 2014, American College of Rheumatology Development and Validation of the HScore, a Score for the Diagnosis of
More informationLEUKAEMIA and LYMPHOMA. Dr Mubarak Abdelrahman Assistant Professor Jazan University
LEUKAEMIA and LYMPHOMA Dr Mubarak Abdelrahman Assistant Professor Jazan University OBJECTIVES Identify etiology and epidemiology for leukemia and lymphoma. Discuss common types of leukemia. Distinguish
More informationAbstract 861. Stein AS, Topp MS, Kantarjian H, Gökbuget N, Bargou R, Litzow M, Rambaldi A, Ribera J-M, Zhang A, Zimmerman Z, Forman SJ
Treatment with Anti-CD19 BiTE Blinatumomab in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (R/R ALL) Post-Allogeneic Hematopoietic Stem Cell Transplantation Abstract
More informationHematology/Oncology/BMT
The University of Arizona Pediatric Residency Program Primary Goals for Rotation Hematology/Oncology/BMT 1. GOAL: Understand the role of the pediatrician in preventing hematologic or oncologic conditions,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423
More information